| Long name: |
FITC Conjugated, RITA/C12orf52 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
RITA/C12orf52 |
| Specificity: |
This is a highly specific antibody against RITA/C12orf52 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human RITA/C12orf52 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
A number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, Noonan syndrome, SH-PTP2, The C12orf52 gene product has been provisionally designated C12orf52 pending further characterization, Trisomy 12p leads to facial development defects, achondrogenesis and Kniest dysplasia, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction, chromosome 12 makes up about 4, is caused by a mutant form of PTPN11 gene product, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy, which includes heart and facial developmental defects among the primary symptoms, 100 genes within 132 million bases, 5% of the human genome, Encoding over 1 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
RITA ZNF463 ZNF361 |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
RITA/C12orf52 Conjugated |
| Short name: |
FITC Conjugated, RITA/C12orf52 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, RITA/C12orf52 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
15489 |
| Gene: |
ZNF331 |
More about : ZNF331 |
| Long gene name: |
zinc finger protein 331 |
| Synonyms name: |
rearranged in thyroid adenomas |
| Locus: |
19q13 |
| Discovery year: |
2003-10-06 |
| GenBank acession: |
AF251515 |
| Entrez gene record: |
55422 |
| RefSeq identity: |
NM_018555 |
| Classification: |
Zinc fingers C2H2-type |
| Havana BLAST/BLAT: |
OTTHUMG00000163019 |
| Locus Specific Databases: |
LRG_1068 |